Abstract
Background In Japan, as a countermeasure against the COVID-19 outbreak, voluntary restrictions against going out (VRG) from a residence were announced from the end of March by national and local governments in preference to lockdowns like those instituted in European and North American countries.
Object We examined some associations among going out information provided by Apple Inc. and estimated an effective reproduction number R(t).
Method We regressed R(t) on a polynomial function of daily Apple Inc. data. From estimation using the whole period, the sub-periods delimited by March 10 were analyzed.
Results Estimation results indicate R(t) as 1.72 if VRG ceases and mobility reverts to a normal level. However, the critical level of R(t)<1 was achieved at a 89.3% of the normal level of mobility.
Discussion and Conclusion Results indicate that a 10% reduction from the normal number of trips will be necessary until herd immunity is achieved. Complete cessation of VRG might not be necessary to avoid re-emergence of the outbreak.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.